RCP

Rho Capital Partners Portfolio holdings

AUM $20.4M
This Quarter Return
+21.2%
1 Year Return
3 Year Return
5 Year Return
10 Year Return
AUM
$132M
AUM Growth
+$12.1M
Cap. Flow
-$18
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
5
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Sector Composition

1 Healthcare 95.52%
2 Communication Services 4.37%
3 Technology 0.11%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
NGM
1
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$69.6M 52.94%
3,766,666
-1
-0% -$18
TVRD
2
Tvardi Therapeutics, Inc. Common Stock
TVRD
$318M
$51.4M 39.1%
88,696
LVO icon
3
LiveOne
LVO
$66.3M
$5.75M 4.37%
3,724,138
MRSN icon
4
Mersana Therapeutics
MRSN
$35.6M
$4.56M 3.47%
31,858
SENS icon
5
Senseonics Holdings
SENS
$375M
$146K 0.11%
159,601